Of genes and phenotypes: The immunological and molecular spectrum of combined immune deficiency. Defects of the γc-JAK3 signaling pathway as a model

Immunological Reviews

Volumn 178, Issue , 2000, Pages 39-48

  Notarangelo, Luigi D ^a,b,c   Giliani, Silvia ^a,b,c   Mazza, Cinzia ^a,b,c   Mella, Patrizia ^a,b,c   Savoldi, Gianfranco ^a,b,c   Rodriguezpérez, Carmen ^a,b,c   Mazzolari, Evelina ^a,b,c   Fiorini, Maurilia ^a,b,c   Duse, Marzia ^a,b,c   Plebani, Alessandro ^a,b,c   Ugazio, Alberto G ^a,b,c   Vihinen, Mauno ^a,b,c   Candotti, Fabio ^a,b,c   Schumacher, Richard F ^a,b,c  

^a UNIVERSITY OF BRESCIA   (Italy)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CYTOKINE; CYTOKINE RECEPTOR; JANUS KINASE;

ANTIGEN EXPRESSION; COMBINED IMMUNODEFICIENCY; GENE MUTATION; HUMAN; IMMUNOGENETICS; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 0034501027     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-065X.2000.17812.x     Document Type: Review

References (78)

1. Essentielle lymphocytophthise
2. Severe combined immunodeficiency: A retrospective single-center study of clinical presentation and outcome in 117 patients
3. Human severe combined immunodeficiency: Genetic, phenotypic, and functional diversity in one hundred eight infants
4. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency
5. Long-term immune reconstitution and outcome after HLA-nonidentical T-cell-depleted bone marrow transplantation for severe combined immunodeficiency: A European retrospective study of 116 patients
6. Long-term chimerism and B-cell function after bone marrow transplantation in patients with severe combined immunodeficiency with B cells: A single-center study of 22 patients
7. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease
8. Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans
9. The interleukin-2 receptor gamma chain maps to Xq13.1 and is mutated in X-linked severe combined immunodeficiency, SCIDX1
10. Development and function oft cells in mice rendered interleukin-2 deficient by gene targeting
11. Severe combined immunodeficiency disease
12. Human immune disorder arising from mutation of the α chain of the interleukin-2 receptor
13. Interleukin-2 receptor γ chain: A functional component of the interleukin-4 receptor
14. Sharing of the interleukin-2 (IL-2) receptor γ chain between receptors for IL-2 and IL-4
15. Interleukin-2 receptor γ chain: A functional component of the interleukin-7 receptor
16. Interaction of IL-2Rβ and γc chains with Jak1 and Jak3: Implications for XSCID and XCID
17. Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15
18. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine
19. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice
20. + severe combined immunodeficiency
21. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation
22. Cytokine receptor signalling
23. Jaks, STATs, cytokine signal transduction, and immunoregulation: Are we there yet?
24. Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID)
25. Mutation of Jak3 in a patient with SCID: Essential role of Jak3 in lymphoid development
26. Structural and functional basis for JAK3-deficient severe combined immunodeficiency
27. Molecular and biochemical characterization of JAK3 deficiency in a patient with severe combined immunodeficiency over 20 years after bone marrow transplantation: Implications for treatment
28. Complete genomic organization of the human JAK3 gene and mutation analysis in severe combined immunodeficiency by single-strand conformation polymorphism
29. Involvement of the Jak-3 Janus kinase in signaling by interleukins 2 and 4 in lymphoid and myeloid cells
30. Interleukins 2, 4, 7, and 15 stimulate tyrosine phosphorylation of insulin receptor substrates 1 and 2 in T cells
31. Cytokine signaling through nonreceptor protein tyrosine kinases
32. STATs: Signal transducers and activators of transcription
33. Advances in the understanding of cytokine signal transduction: The role of Jaks and STATs in immunoregulation and the pathogenesis of immunodeficiency
34. Signaling via IL-2 and IL-4 in JAK3-deficient severe combined immunodeficiency lymphocytes: JAK3-dependent and independent pathways
35. Interleukin-4 signaling in B lymphocytes from patients with X-linked severe combined immunodeficiency
36. cDNA cloning and characterization of the human interleukin 13 receptor γ chain
37. Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor
38. IL2RGbase: A database of γc-chain defects causing human X-SCID
39. Deficient expression of Bruton's tyrosine kinase in monocytes from X-linked agammaglobulinemia as evaluated by a flow cytometric analysis and its clinical application to carrier detection
40. Flow cytometric analysis of Wiskott-Aldrich syndrome (WAS) protein in lymphocytes from WAS patients and their familial carriers
41. X-linked thrombocytopenia identified by flow cytometric demonstration of defective Wiskott-Aldrich syndrome protein in lymphocytes
42. Mutations of the CD40 ligand gene and its effect on CD40 ligand expression in patients with X-linked hyper IgM syndrome
43. Diagnosis of X-linked lymphoproliferative disease by analysis of SLAM-associated protein expression
44. T-lymphocyte differentiation and proliferation in the absence of the cytoplasmic tail of the common cytokine receptor γc chain in a severe combined immune deficiency X1 patient
45. Missense mutation in exon 7 of the common gamma chain gene causes a moderate form of X-linked combined immunodeficiency
46. Defective human interleukin 2 receptor-γ chain in an atypical X chromosome-linked severe combined immunodeficiency with peripheral T cells
47. An interleukin-2 receptor γ chain mutation with normal thymus morphology
48. Functional role of interleukin-4 (IL-4) and IL-7 in the development of X-linked severe combined immunodeficiency
49. Development of autologus T lymphocytes in two males with X-linked severe combined immune deficiency: Molecular and cellular characterization
50. Atypical X-linked severe combined immunodeficiency due to possible spontaneous reversion of the genetic defect in T cells
51. The interleukin-2 and interleukin-4 receptors studied by molecular modelling
52. Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor γ chain
53. Defective lymphoid development in mice lacking expression of the common cytokine receptor γ chain
54. Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3
55. Developmental defects of lymphoid cells in Jak3 kinase-deficient mice
56. Defective lymphoid development in mice lacking Jak3
57. Reconstitution of early lymphoid proliferation and immune function in Jak3-deficient mice by interleukin-3
58. JAK3 maps to human chromosome 19p12 within a cluster of proto-oncogenes and transcription factors
59. JAK3: Expression and mapping to chromosome 19p12-13.1
60. Revised exon-intron structure of human JAK3 locus
61. Molecular modelling of the JAK3 kinase domain and structural basis for severe combined immunodeficiency (SCID)
62. Autosomal SCID caused by a point mutation in the N-terminus of Jak3: Mapping of the Jak3-receptor interaction domain
63. Complex effects of naturally occurring mutations in the JAK3 pseudokinase domain: Evidence for interactions between the kinase and pseudokinase domains
64. Prenatal diagnosis of JAK3 deficient SCID
65. Development of autologous, oligoclonal, poorly functioning T lymphocytes in a patient with autosomal recessive severe combined immunodeficiency caused by defects of the Jak3 tyrosine kinase
66. Peripheral expression of Jak3 is required to maintain T lymphocyte function
67. In-utero transplantation of parental CD34 haematopoietic progenitor cells in a patient with X-linked severe combined immunodeficiency (SCIDXI)
68. Treatment of X-linked severe combined immunodeficiency by in utero transplantation of paternal bone marrow
69. Retroviral-mediated gene correction for X-linked severe combined immunodeficiency
70. In vitro correction of JAK3-deficient severe combined immunodeficiency by retroviral-mediated gene transduction
71. γc gene transfer into SCID X1 patients' B-cell lines restores normal high-affinity interleukin-2 receptor expression and function
72. - X-linked severe combined immunodeficiency hematopoietic progenitor cells in murine fetal thymic organ cultures
73. Stable and functional lymphoid reconstitution of common cytokine receptor γ chain deficient mice by retroviral-mediated gene transfer
74. Retroviral marking of canine bone marrow: Long-term, high-level expression of human interleukin-2 receptor common γ chain in canine lymphocytes
75. Restoration of lymphoid populations in a murine model of X-linked severe combined immunodeficiency by a gene-therapy approach
76. Lymphoid development and function in X-linked severe combined immunodeficiency mice after stem cell gene therapy
77. Restoration of lymphocyte function in Janus kinase 3-deficient mice by retroviral-mediated gene transfer
78. Virus-specific immunity after gene therapy in a murine model of severe combined immunodeficiency